{
  "id": "befe3fe6049f0991",
  "title": "Belgian Immune System Drugmaker AgomAb Files for US IPO",
  "description": "AgomAb Therapeutics NV filed for a initial public offering in the US to help fund trials of its drugs to treat immune and inflammation diseases.",
  "content": "AgomAb Therapeutics NV filed for a initial public offering in the US to help fund trials of its drugs to treat immune and inflammation diseases.",
  "source": "Bloomberg Markets",
  "source_url": "https://www.bloomberg.com/news/articles/2026-01-16/belgian-immune-system-drugmaker-agomab-files-for-us-ipo",
  "published_at": "2026-01-16T23:05:19+00:00",
  "fetched_at": "2026-01-17T00:22:29.333379+00:00",
  "category": "macroeconomics_finance",
  "subcategory": null,
  "keywords": [
    "ipo",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "Belgian Immune System Drugmaker AgomAb Files for US IPO",
    "description": "AgomAb Therapeutics NV filed for a initial public offering in the US to help fund trials of its drugs to treat immune and inflammation diseases.",
    "url": "https://www.bloomberg.com/news/articles/2026-01-16/belgian-immune-system-drugmaker-agomab-files-for-us-ipo",
    "published": "2026-01-16T23:05:19+00:00",
    "source": "Bloomberg Markets"
  }
}